Camp4 Therapeutics vs Ocugen
Ocugen is the larger business, with $4.4m of revenue in fiscal 2025 against $3.5m for Camp4 Therapeutics (1.3 times as much). Camp4 Therapeutics grew faster (436.5% against 8.8%). Ocugen kept more of each dollar of sales as profit: a net margin of -1537.4% against -2298.5%.
| Latest fiscal year | Camp4 TherapeuticsCAMP, 2025 | OcugenOCGN, 2025 |
|---|---|---|
| Revenue | $3.5m | $4.4m |
| Revenue growth | 436.5% | 8.8% |
| Net income | −$80.4m | −$67.8m |
| Operating margin | -1502.4% | -1425.7% |
| Net margin | -2298.5% | -1537.4% |
| Return on equity | -145.1% | — |
| Free cash flow | −$29.8m | −$57.1m |
| Cash | $110m | $18.6m |
| Total debt | $0 | $31.5m |
| Debt to equity | 0.0% | — |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 48 | 116 |
| Market value | $201m | $253m |
| Price vs our value range | — | — |
| Moat score | — | 8 (Weak) |
| Insider trades, 12 months | 5 buys, 6 sales | 1 buys, 4 sales |